Mantra Bio

Biotechnology, Life Science
Founded in 1/1/16
San Francisco, California, United States
For Profit

About Mantra Bio

Mantra Bio develops a novel next-generation, targeted therapeutics based on its proprietary platform for engineering Targeted Exosome Vehicles (TEVs). The Company's REVEAL platform, which integrates computational and wet biology, and automation, leverages the diversity of exosomes to enable the rational design of therapeutics directed at a wide range of tissue and cellular targets. Mantra Bio has also established a scalable biomanufacturing process and related technologies to ensure this new class of therapeutics is reproducibly made at high purity.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: 14 active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 34000000 USD
  • Last Funding: 9000000 USD (Series A)
  • Funding Status: Early Stage Venture

Technology Stack

Mantra Bio actively uses 14 products in their tech stack.

Market Presence

Industries: Biotechnology, Life Science

Headquarters: San Francisco, California, United States

Employees

  • Alex Mok - Co-Founder & Chief Executive Officer (LinkedIn)
  • Maria Fuentes - Chief Scientific Officer (LinkedIn)